Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/TIZIANA-LIFE-SCIENCES-LTD-128528512/actualite/Tiziana-Life-Sciences-Ltd-Dosage-du-premier-patient-dans-l-etude-de-phase-2A-sur-le-foralumab-intr-45599560/?utm_source=whatsapp&utm_medium=social&utm_campaign=share